XpresCheck® Opens COVID-19 Testing Facility at Orlando International Airport
March 30 2022 - 8:00AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has opened a
new XpresCheck® COVID-19 testing facility at Orlando International
Airport (MCO).
XpresCheck is located pre-security, in the South
Walk area in the Main Terminal. COVID-19 testing options include a
Rapid RT-PCR test and the standard Polymerase Chain Reaction (PCR)
Test.
Scott Milford, XpresSpa CEO, said, "We are
pleased to be opening a convenient XpresCheck testing facility at
Orlando International Airport. Demand for reliable COVID-19 testing
remains strong as passengers seek to travel, especially to
international destinations. Orlando has been a great market for our
XpresSpa wellness locations and we are pleased to be able to
complement that offering with health services through
XpresCheck.”
“The continuation of airport programs like this
one helps us to further enhance our public health surveillance of
emerging infectious diseases that have traditionally focused on
health clinics after the onset of symptoms, but with the new
variant Omicron sub-lineage BA.2 and BA.3 continuing to circulate
globally, new openings at locations such as Orlando International
Airport help support our continued biosecurity efforts and
underscore the importance of continued public-private
partnerships,” said Ezra Ernst, CEO, XpresCheck.
About XpresSpa Group,
Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a
leading global health and wellness holding company operating three
distinct brands: XpresCheck®, XpresSpa®, Treat™. XpresCheck is
a leading on-site airport provider of COVID-19 screening and
testing with 16 locations in 13 domestic airports. XpresSpa is a
leading airport retailer of spa services and related health and
wellness products, with 45 locations in 21 airports globally. Treat
is a travel health and wellness brand that is providing on-demand
access to healthcare through technology and personalized services.
The Company also recently acquired HyperPointe™, a leading digital
healthcare and data analytics relationship marketing agency
servicing the global healthcare and pharmaceutical industry.
To learn more about XpresSpa Group, visit:
www.XpresSpaGroup.comTo learn more about XpresCheck, visit:
www.XpresCheck.comTo learn more about XpresSpa, visit:
www.XpresSpa.comTo learn more about Treat, visit: www.Treat.comTo
learn more about HyperPointe, visit: www.Hyperpointe.com
Twitter: @xprescheck and Instagram: @realxprescheckTwitter:
@XpresSpa and Instagram: @XpresSpaTwitter: @Treat_Care and
Instagram: @treat_care
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. Forward-looking statements relating to expectations
about future results or events are based upon information available
to XpresSpa Group as of today's date and are not guarantees of the
future performance of the Company, and actual results may vary
materially from the results and expectations discussed. Additional
information concerning these and other risks is contained in
XpresSpa Group’s Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q and Current Reports on Form 8-K, and other Securities and
Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie
FergusonJulie@jfprmedia.com(312) 385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2024 to May 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From May 2023 to May 2024